2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases

References

• Angeli A, Carta F, Supuran CT. Carbonic anhydrases: versatile and useful biocatalysts in chemistry and biochemistry. Catalyst 2020;10:1008.
   Google Scholar
• a) Jensen EL, Clement R, Kosta A, et al. A new widespread subclass of carbonic anhydrase in marine phytoplankton. Isme J 2019;13:2094–106.b) Nocentini A, Supuran CT, Capasso C. An overview on the recently discovered iota-carbonic anhydrases. J Enzyme Inhib Med Chem 2021;36:1988–95.
   PubMed Web of Science ®Google Scholar
• Kurt BZ, Dag A, Doğan B, et al. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Bioorg Chem 2019;87:838–50.
   PubMed Web of Science ®Google Scholar
• Aspatwar A, Tolvanen MEE, Parkkila S. An update on carbonic anhydrase-related proteins VIII, X and XI. J Enzyme Inhib Med Chem 2013;28:1129–42.
   PubMed Web of Science ®Google Scholar
• Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000;80:681–715.
   PubMed Web of Science ®Google Scholar
• Lee D, Hong JH. The fundamental role of bicarbonate transporters and associated carbonic anhydrase enzymes in maintaining ion and pH homeostasis in non-secretory organs. Int J Mol Sci 2020;21:339.
   PubMed Web of Science ®Google Scholar
• a) Henry RP. Multiple roles of carbonic anhydrase in cellular transport and metabolism. Annu Rev Physiol 1996;58:523–38.b) Supuran   Novel carbonic anhydrase inhibitors. Future Med Chem 2021;13:1935–7.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Mincione F, Somma T, et al. A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 2012;27:138–47.
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Kondeti B, McKenna R. Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 2013;23:717–24.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Alterio V, Bua S, et al. Phenyl(thio)phosphon(amid)ate benzenesulfonamides as potent and selective inhibitors of human carbonic anhydrases II and VII counteract allodynia in a mouse model of oxaliplatin-induced neuropathy. J Med Chem 2020;63:5185–200.
   PubMed Web of Science ®Google Scholar
• Di Cesare Mannelli L, Micheli L, Carta F, et al. Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors. J Enzyme Inhib Med Chem 2016;31:894–9.
   PubMed Web of Science ®Google Scholar
• Costa G, Carta F, Ambrosio FA, et al. A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors. Eur J Med Chem 2019;181:111565.
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
• Provensi G, Carta F, Nocentini A, et al. A new kid on the block? Carbonic anhydrases as possible new targets in Alzheimer's disease. Int J Mol Sci 2019;20:4724.
   PubMed Web of Science ®Google Scholar
• a) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12.b) Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021;135:1233–49.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase activators. Future Med Chem 2018;10:561–73.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Kim JK, Lee C, Lim SW, et al. Elucidating the role of metal ions in carbonic anhydrase catalysis. Nat Commun 2020;11:4557.
   PubMed Web of Science ®Google Scholar
• Annunziata F, Pinna C, Dallavalle S, et al. An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities. Int J Mol Sci 2020;21:4618.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Coumarin carbonic anhydrase inhibitors from natural sources. J Enzyme Inhib Med Chem 2020;35:1462–70.
   PubMed Web of Science ®Google Scholar
• Stefanachi A, Leonetti F, Pisani L, et al. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules 2018;23:250.
   PubMed Web of Science ®Google Scholar
• Medina FG, Marrero JG, Macías-Alonso M, et al. Coumarin heterocyclic derivatives: chemical synthesis and biological activity. Nat Prod Rep 2015;32:1472–507.
   PubMed Web of Science ®Google Scholar
• Kostova I, Bhatia S, Grigorov P, et al. Coumarins as antioxidants. Curr Med Chem 2011;18:3929–51.
   PubMed Web of Science ®Google Scholar
• Miao Y, Yang J, Yun Y, et al. Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives. J Enzyme Inhib Med Chem 2021; 36:450–61.
   PubMed Web of Science ®Google Scholar
• Hu Y, Shen Y, Wu X, et al. Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents. Eur J Med Chem 2018;143:958–69.
   PubMed Web of Science ®Google Scholar
• Mzezewa SC, Omoruyi SI, Zondagh LS, et al. Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents. J Enzyme Inhib Med Chem 2021; 36:1607–21.
   PubMed Web of Science ®Google Scholar
• Jiang N, Huang Q, Liu J, et al. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2018;146:287–98.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu J, Liu Y, et al. A review on anti-tumor mechanisms of coumarins. Front Oncol 2020;10:592853.
   PubMed Web of Science ®Google Scholar
• Al-Warhi T, Sabt A, Elkaeed EB, Eldehna WM. Recent advancements of coumarin-based anticancer agents: an up-to-date review. Bioorg Chem 2020;103:104163.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. J Enzyme Inhib Med Chem 2021;36:1702–14.
   PubMed Web of Science ®Google Scholar
• Koyiparambath VP, Rajappan KP, Rangarajan TM, et al. Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—an updated review. Chem Biol Drug Des 2021;98:655–73.
   PubMed Web of Science ®Google Scholar
• Liu H, Xia DG, Chu ZW, et al. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase inhibitors: design, synthesis, and antibacterial activity. Bioorg Chem 2020;100:103907.
   PubMed Web of Science ®Google Scholar
• Era B, Delogu GL, Pintus F, et al. Looking for new xanthine oxidase inhibitors: 3-phenylcoumarins versus 2-phenylbenzofurans. Int J Biol Macromol 2020;162:774–80.
   PubMed Web of Science ®Google Scholar
• Hng Y, Lin MH, Lin TS, et al. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors. Bioorg Chem 2020;96:103618.
   PubMed Web of Science ®Google Scholar
• Xu X-T, Deng X-Y, Chen J, et al. Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors. Eur J Med Chem 2020;189:112013.
   PubMed Web of Science ®Google Scholar
• Lagunes I, Begines P, Silva A, et al. Selenocoumarins as new multitarget antiproliferative agents: synthesis, biological evaluation and in silico calculations. Eur J Med Chem 2019;179:493–501.
   PubMed Web of Science ®Google Scholar
• Abdizadeh T, Kalani MR, Abnous K, et al. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. Eur J Med Chem 2017;132:42–62.
   PubMed Web of Science ®Google Scholar
• de Souza LG, Rennã MN, Figueroa-Villar JD. Coumarins as cholinesterase inhibitors: a review. Chem Biol Interact 2016;254:11–23.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62.
   PubMed Web of Science ®Google Scholar
• De Luca L, Mancuso F, Ferro S, et al. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases. Eur J Med Chem 2018;143:276–82.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44.
   PubMed Web of Science ®Google Scholar
• Krasavin M, Kalinin S, Sharonova T, Supuran CT. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents. J Enzyme Inhib Med Chem 2020;35:1555–61.
   PubMed Web of Science ®Google Scholar
• a) Betof AS, Rabbani ZN, Hardee ME, et al. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification. Br J Cancer 2012;106:916–22. ‒b) Chafe SC, Vizeacoumar FS, Venkateswaran G, et al. Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv 2021;7:eabj0364.
   PubMed Web of Science ®Google Scholar
• Salaroglio IC, Mujumdar P, Annovazzi L, et al. Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma. Mol Cancer Ther 2018;17:2598–609.
   PubMed Web of Science ®Google Scholar
• Reddy GM, Kumari AK, Reddy VH, Garcia JR. Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: design, synthesis, microbial resistance and machine aided results. Bioorg Chem 2020;100:103908.
   PubMed Web of Science ®Google Scholar
• Fulmer GR, Miller AJM, Sherden NH, et al. NMR chemical shifts of trace impurities: common laboratory solvents, organics, and gases in deuterated solvents relevant to the organometallic chemist. Organometallics 2010;29:2176–9.
   Web of Science ®Google Scholar
• Elshaflu H, Todorović TR, Nikolić M, et al. Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: experimental and In-silico studies. Front Chem 2018;6:247.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000;28:235–42.
   PubMed Web of Science ®Google Scholar
• Zambare AS, Khan FAK, Zambare SP, et al. Recent advances in the synthesis of coumarin derivatives via Pechmann condensation. Curr Org Chem 2016;20:798–828.
   Web of Science ®Google Scholar
• Lake BG, Evans JG, Lewis DFV, Price RJ. Studies on the acute effects of coumarin and some coumarin derivatives in the rat. Food Chem Toxicol 1994;32:357–63.
   PubMed Web of Science ®Google Scholar
• Yadav VK, Srivastava VP, Yadav LDS. Iodide catalyzed synthesis of 2-aminobenzoxazoles via oxidative cyclodesulfurization of phenolic thioureas with hydrogen peroxide. Tetrahedron Lett 2018;59:252–5.
   Google Scholar
• Swain B, Angeli A, Angapelly S, et al. Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors. J Enzyme Inhib Med Chem 2019;34:1199–209.
   PubMed Web of Science ®Google Scholar
• a) Briganti F, Pierattelli R, Scozzafava A, Supuran CT, Carbonic anhydrase inhibitors. Part 37. Novel classes of carbonic anhydrase inhibitors and their interaction with the native and cobalt-substituted enzyme: kinetic and spectroscopic investigations. Eur J Med Chem 1996; 31:3. 1001–10.b) Innocenti A, Gülçin I, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett 2010; 20:5050–3.
   Web of Science ®Google Scholar
• Bua S, Lucarini L, Micheli L, et al. Bioisosteric development of multitarget nonsteroidal anti-inflammatory drug-carbonic anhydrases inhibitor hybrids for the management of rheumatoid arthritis. J Med Chem 2020;63:2325–42.
   PubMed Web of Science ®Google Scholar
• Touisni N, Maresca A, McDonald PC, et al. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011;54:8271–7.
   PubMed Web of Science ®Google Scholar
• Mancuso F, De Luca L, Angeli A, et al. Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII. J Enzyme Inhib Med Chem 2020;35:1442–9.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Deplano S, Maccioni E, et al. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. J Enzyme Inhib Med Chem 2021;36:685–92.
   PubMed Web of Science ®Google Scholar